Product Highlight - Reloxa

Relax, we’ve got acid disorders covered

• Rabeprazole sodium (Reloxa) is indicated for the treatment of: Active duodenal ulcer, active benign gastric ulcer, symptomatic erosive or ulcerative gastroesophageal reflux disease (GERD), eradication of H. pylori-positive duodenal ulcers and maintenance treatment of healed erosive or ulcerative GERD.¹

REFERENCES:
1. Full prescribing information of Reloxa (available upon request to The Cathay Drug Co., Inc.)